Rare diseases
Investigational molecules
Locations
Back to Germany251 clinical trials in Magdeburg, Germany across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
GermanyRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
GermanyZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
GermanyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
GermanyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GermanyLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
GermanyStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on innovative treatments for various cancer types, including breast cancer, lymphoma, and pancreatic cancer. Studies evaluate new therapeutic approaches and combination treatments.
Particular emphasis on targeted therapies and immunotherapy approaches for better patient outcomes.
Research focusing on chronic skin conditions and innovative treatments for psoriasis and other dermatological disorders. Multiple trials investigating new therapeutic options.
Studies aim to improve quality of life through advanced therapeutic approaches.
Investigations into treatments for cardiovascular disease and metabolic disorders, including innovative approaches for managing hypertriglyceridemia and diabetes.
Focus on preventive strategies and novel therapeutic interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
